EDWARD BURKE: Open Payments
NPI 1306885157 · FREDERICKTOWN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 52 payments from 16 companies in 2025. Trend: 2023 $397 · 2024 $418 · 2025 $898
Food & beverage: $810Education: $87
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $198 |
| Lundbeck LLC | 10 | $139 |
| Teva Pharmaceuticals USA, Inc. | 1 | $87 |
| MIMEDX Group, Inc. | 1 | $83 |
| PFIZER INC. | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $41 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Novo Nordisk Inc | 1 | $21 |
Products named: REXULTI, VRAYLAR, NURTEC ODT, UBRELVY, CAPLYTA, TRELEGY ELLIPTA, BREZTRI, Ozempic.
Industry payments across MO — which companies pay providers there.
